Side Effect: Restless Leg Syndrome

What is Restless Leg Syndrome?

Restless leg syndrome is a condition where patients feel an uncontrollable urge to move their legs. Usually this is paired with uncomfortable sensations like tingling. The sensations typically occur at night or when resting, leading to difficulty falling or staying asleep.

What does Restless Leg Syndrome look like?

Restless leg syndrome can present in different ways, but most common symptoms include:

Patients may constantly adjust their leg position, shake the legs, or walk around to help alleviate symptoms temporarily. These movements help temporarily, but the symptoms often return when the legs are still again. Restless leg syndrome can significantly disrupt sleep, leading to fatigue and daytime drowsiness.

Who gets Restless Leg Syndrome?

Patients with cancer are at risk of getting restless leg syndrome because of several factors. Certain chemotherapies, iron deficiency from cancer or chemotherapy, or radiation treatment can contribute to its development. Restless leg syndrome can occur in all ages, but it is most common in middle-aged, older, and female adults. Additionally, some medicines or substances can increase risk or worsen symptoms including caffeine, nicotine, or alcohol.

How to prevent Restless Leg Syndrome

Preventing restless leg syndrome in patients with cancer might include ensuring adequate iron levels, managing medications that could be contributing, and promoting healthy sleep habits. Below are some tips to help prevent restless leg syndrome in patients with cancer:

How to treat Restless Leg Syndrome

Treatment of restless leg syndrome in patients with cancer involves a variety of approaches that focus on the cause rather than curing the condition. Some of the most common methods, techniques, and medications are:

References

1) Elstrott B, Khan L, Olson S, et al. The role of iron repletion in adult iron deficiency anemia and other diseases. Eur J Haematol 2020;104(3):153-161

2) Hernandez-Con P, Shults J, Willis AW, Yang YX. Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiol Drug Saf 2023;32(7):726-734

3) Jim HS, Evans B, Jeong JM, et al. Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management. Biol Blood Marrow Transplant 2014;20(10):1465-1484

Created: June 5, 2024 Updated: July 17, 2024